Duvakitug

6 trials 2 recruiting

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

2 Recruiting

2 Completed trials

2 Sponsors

15 Countries

Phase III

Phase II

Phase III: 4 Phase II: 2

Indications tested

Colitis ulcerative 2 Crohn´s disease 2

Sponsors using this IMP

Sanofi-Aventis Recherche & Developpement 4 Teva Branded Pharmaceutical Products R&D LLC 2

All trials

6 total

A maintenance study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn’s disease Pending

2025-521037-86-00 Phase III 15 countries Sanofi-Aventis Recherche & Developpement
A maintenance study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active ulcerative coliti… Pending

2025-521038-27-00 Phase III 15 countries Sanofi-Aventis Recherche & Developpement
An induction study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn's Disease Recruiting

2025-521036-11-00 Phase III 15 countries Sanofi-Aventis Recherche & Developpement
An induction study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcerative Colitis Recruiting

2025-521035-37-00 Phase III 15 countries Sanofi-Aventis Recherche & Developpement
A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn’s Disease Ended

2024-515027-11-00 Phase II 10 countries Teva Branded Pharmaceutical Products R&D LLC
A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn’s Disease Ended

2024-511089-36-00 Phase II 12 countries Teva Branded Pharmaceutical Products R&D Inc.

Showing 1–6 of 6 trials

← All drugs A–Z